Mazoyer E - Search Results

1

[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?].

Karmochkine M, Piette JC, Mazoyer E, Wechsler B, Chérin P, Herson S, Godeau P, Boffa MC. Karmochkine M, et al. Among authors: mazoyer e. Presse Med. 1995 Feb 4;24(5):267-70. Presse Med. 1995. PMID: 7899382 Review. French.

2

High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation.

Karmochkine M, Mazoyer E, Marcelli A, Boffa MC, Piette JC. Karmochkine M, et al. Among authors: mazoyer e. Thromb Haemost. 1996 Jun;75(6):971. Thromb Haemost. 1996. PMID: 8822595 No abstract available.

3

Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind study.

Samama CM, Mazoyer E, Bruneval P, Ciostek P, Bonnin P, Bonneau M, Roussi J, Bailliart O, Pignaud G, Viars P, et al. Samama CM, et al. Among authors: mazoyer e. Thromb Haemost. 1994 May;71(5):663-9. Thromb Haemost. 1994. PMID: 7522355

4

Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig.

Samama CM, Bonnin P, Bonneau M, Pignaud G, Mazoyer E, Bailliart O, Maffrand JP, Viars P, Caen JP, Drouet LO. Samama CM, et al. Among authors: mazoyer e. Thromb Haemost. 1992 Nov 10;68(5):500-5. Thromb Haemost. 1992. PMID: 1455394

5

[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit].

Pham Tourreau S, Fattorutto M, Bonnin P, Mazoyer E, Raphaël M, Morin F, Cupa M, Samama CM. Pham Tourreau S, et al. Among authors: mazoyer e. Ann Fr Anesth Reanim. 2003 Dec;22(10):870-8. doi: 10.1016/j.annfar.2003.08.007. Ann Fr Anesth Reanim. 2003. PMID: 14644369 French.

6

Severe arterial thrombosis in a congenitally factor VII deficient patient.

Escoffre M, zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E. Escoffre M, et al. Among authors: mazoyer e. Br J Haematol. 1995 Nov;91(3):739-41. doi: 10.1111/j.1365-2141.1995.tb05378.x. Br J Haematol. 1995. PMID: 8555085

7

The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.

Drouet L, Bal dit Sollier C, Cisse M, Pignaud G, Mazoyer E, Fiat AM, Jolles P, Caen JP. Drouet L, et al. Among authors: mazoyer e. Nouv Rev Fr Hematol (1978). 1990;32(1):59-62. Nouv Rev Fr Hematol (1978). 1990. PMID: 2349083

8

How does ticlopidine treatment lower plasma fibrinogen?

Mazoyer E, Ripoll L, Boisseau MR, Drouet L. Mazoyer E, et al. Thromb Res. 1994 Aug 1;75(3):361-70. doi: 10.1016/0049-3848(94)90251-8. Thromb Res. 1994. PMID: 7992249 Review.

9

Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.

Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM. Godier A, et al. Among authors: mazoyer e. J Thromb Haemost. 2007 Feb;5(2):244-9. doi: 10.1111/j.1538-7836.2007.02320.x. Epub 2006 Nov 27. J Thromb Haemost. 2007. PMID: 17129221 Free article.

10

Platelet membrane glycoproteins and platelet functions during storage in the presence of a proteinase inhibitor.

Mazoyer E, Boizard-Boval B, Pidard D, Caen J, Wautier JL. Mazoyer E, et al. Thromb Res. 1991 May 1;62(3):165-75. doi: 10.1016/0049-3848(91)90190-8. Thromb Res. 1991. PMID: 1716381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters